AIM: This study was designed to compare the safety and feasibility of uterine fibroid embolisation (UFE) via transradial access (TRA) and transfemoral access (TFA).
Introduction
Uterine fibroids are the most common gynaecological benign tumours in women and can cause symptoms like severe menstrual bleedings with or without repercussion of blood account, pelvic or abdominal pain, swelling, urinary tract symptoms, bowel compression etc. Uterine fibroid embolisation (UFE) is a minimally invasive endovascular procedure which is performed for the treatment of fibroids. On the other hand, surgery is the standard treatment of choice for this pathology offered by gynaecologists. Hysterectomy and myomectomy, both in the classical or laparoscopic way are the most common surgical techniques. UFE is an established endovascular interventional technique which includes delivery of embolic agents through the uterine arteries directly in uterus and fibroids. This intervention is typically offered to women who refuse surgery.
Further it is commonly practiced in women who want to preserve their uterus by any means, who are contraindicated to surgery due to comorbidities, younger women etc. Traditionally, transfemoral access (TFА) has been the standard approach for performing this intervention as well as for other procedures in interventional radiology (IR), proven in a number of studies so far. Transradial access (TRА) is a relatively new approach in interventional radiology (IR) and so far has been used predominantly in interventional cardiology for the past few decades. Due to improved patient comfort, minor access site complications, earlier ambulation and reduced costs, TRA is becoming more popular also in some IR procedures such as: visceral embolizations with predominance of transarterial chemoembolization https://www.id-press.eu/mjms/index (TACE) and radioembolization (TARE), embolization of gastrointestinal bleedings, carotid artery stenting and lately in some centers also for UFE. Reviewing the literature on this particular topic, there are not many papers connecting TRA and UFE. Those few small series published speak for its safety and good feedback from patients. In our hospital, UFE has been practiced from 2015, and from the end of 2017 we started using TRA for this procedure.
In this article, we present our initial experience using TRA for UFE compared to that of TFA regarding the safety profile and the procedural eligibility.
Material and Methods
Institutional review board approval was obtained for this retrospective study. Retrospective analysis was conducted for twenty-four women with UFE with 29 fibroids in the period from February 2016 to October 2018, reviewing our hospital information system. Thirteen women with TFA and eleven with TRA embolisation of uterine fibroid mean age 39 y. (range 29-47 y.) were analysed. Twenty-one of them (87.5%) have already completed reproduction, with at least one childbirth, with no particular desire for further reproduction. Two of them (8.3%) have no children (in these two myomas/fibroids were considered as one of the possible causes of infertility). One woman (4.1%) with one child, with a desire for another conception in future. All patients were symptomatic and indications for embolization included: heavy menstrual bleedings (n = 18) 75%, lower urinary tract symptoms (n = 2) 8.3%, pelvic pain (n = 3) 12.5% and abdominal pain (n = 1) 4.1%. Demographic patient characteristics between the two groups did not differ significantly (Table 1) . Patients were divided into 2 groups: 13 cases with already established TFA (from February 2016 to September 2018) and the first 11 procedures performed via TRA (from October 2017 to October 2018). All procedures were performed by one interventional radiologist with experience of more than 400 visceral embolisations and one fellow in Radiology. In the TFA group, standard Seldinger technique was used with 5F introducer in the right common femoral artery (CFA). 5F Cobra 2 catheter was used for catheterisation of left internal iliac artery and Simmons 2 catheter for right internal iliac artery. In all femoral cases, 2,7F 130cm long microcatheter (Program, Terumo, Japan) was used for superselective catheterisation of uterine arteries and consequent embolisation.
Figure 1: Pelvic MRI; T1 FS contrast-enhanced axial MRI of uterus pre embolisation shows 2 large intramural hypervascular fibroids (arrow) in the left side of uterus body with a displacement of cavum uteri
In the TRA group, the preprocedural US of the radial artery was performed together with Barbeau test for depicting patency of hand vessels. Radial arteries smaller than 2.5 mm in diameter were considered as too small for puncture, and these patients were excluded from radial puncture and converted to femoral access. Micropuncture set for transradial access (5F Slender Glidesheath, Terumo, Japan) was used in all radial cases with 110 cm MP or 125 angled catheter for cannulation of hypogastric artery. One 150 cm long 2.8F microcatheter (Program, Terumo, Japan) in combination with GT microwire was chosen for uterine artery super selective catheterisation. Left radial artery was used for all of the eleven TRA cases. Embolisation was performed by using PVA or PEG particles with size from 500-1000 microns. Type and size of particles were selected as per every case on the discretion of the operator. 
8F 150 cm long microcatheter shows large hypervascular fibroid; B) Postembolization angiography in the same patient shows complete embolization of left uterine artery with PVA particles and stasis of contrast at the tip of microcatheter while mail uterine artery is still patent
Haemostasis of the femoral artery was achieved with manual compression, and haemostasis of the radial artery was done with TR Band (Terumo Interventional Systems) in all cases.
Pelvic contrast-enhanced MRI and complete blood account tests were assessed before intervention in every case. The degree of achieved necrosis of the fibroids was assessed by control pelvic enhanced MRI 1-2 months after embolisation.
Conversation with the interventional radiologist about improving symptoms and quality of life, complete blood tests and radial artery ultrasound was also part of the postprocedural follow up at 1 month interval.
Figure 5: One and a half month post embolisation T1 FS contrastenhanced axial MRI of the uterus in the same patient shows complete necrosis of both fibroids (arrow) and preservation of uterine body wall with normal enhancement

Results
Technical success of the procedure was achieved in 24/24 cases (100%). Unilateral uterine artery embolisation was performed in 7 cases (29.1%) and bilateral in 17 cases (70.8%). The decision for unilateral UFE was made by carefully reviewing of the preprocedural US and MRI, and in all these cases fibroids were predominantly vascularized by one uterine artery (> 80%). Mean procedural time was 72.4 minutes in TFA group, and 60.3 minutes in the TRA group. Mean fluoroscopy time was 25.3 minutes in the TFA group and 21.1 minutes in the TRA group. Access site-related and overall adverse events did not vary significantly among the study cohorts. One nonflow-limiting dissection of left internal iliac artery occurred in the TFA group during manipulation with hydrophilic wire which resolved spontaneously at the end of the procedure. In one patient in the TRA group, there was prolonged pain in the left forearm for 14 days which was managed conservatively with use of non-steroidal anti-inflammatory drugs.
Patients in the TRA group left the hospital the same day 3-4 hours after the procedure with a bandage at the left radial artery. In the TFA group patients stayed in the hospital for two nights, one day prior and one day after the procedure. There were no late major complications in both groups. In all TRA cases, radial artery remained patent without signs of thrombosis, which was confirmed with the US on onemonth control examination. https://www.id-press.eu/mjms/index
Discussion
Transfemoral approach for uterine artery embolisation is an established technique for the treatment of uterine fibroids. Different catheters and manoeuvres have been described in the literature for cannulation of uterine arteries via transfemoral access. In recent years, transradial approach is gaining more and more popularity in the IR community, especially for some visceral artery interventions. It's proven safety and benefits in interventional cardiology interventions by a number of studies was followed by some small series in interventional radiology as well.
In this retrospective review of procedural safety and efficacy in a small cohort of patients treated with transradial approach, we did not observe any major complications during or after the procedure. Fluoroscopy time was less than that in TFA group without any statistical significance and we found that cannulation of the uterine artery is almost always easier when we used TRA. Main advantage so far is that the procedure can be performed as an outpatient one without patient hospitalisation. This was proven to be of great importance for patients when we were doing the postprocedural questionary. According to the results from this study, we can clearly say that TRA is a safe and effective alternative to TFA for UFE in carefully selected patients.
Evеry woman with the radial artery of 3 mm or greater diameter is a candidate for transradial UFE. Compared to TFA, there is shorter hospital stay and reduced total costs in the TRA procedure.
Limitations of the study: This is a small, retrospective study for gaining large and long-term conclusions. Also, it is a single centre so we cannot compare or share the results from other centres as well.
In conclusion, we think that TRA is potentially safe end effective approach for uterine fibroid embolisation. According to our experience so far it appears to be a highly promising treatment option for a woman with symptomatic fibroids. The main advantage of this procedure is early verticalization of the patients and same day discharge from the hospital.
Potential limitations so far are the lack of adequate materials (catheters and microcatheters) that can easily reach the ostium of every uterine artery via radial access. Also, the diameter of radial artery and total body height of the patient is a very important prognostic factor that can influence the success of the procedure.
Further studies with larger numbers of patients with follow-ups on longer intervals are necessary to assess the effectivness of TRA for uterine fibroid embolization better.
